TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 1.60nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 7.80nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 15.3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 20nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 20.5nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 22nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 40.6nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 55.6nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 70nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 96.3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 121nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 182nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 371nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand InfoPurchase
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 1.11E+3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 3.08E+3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 3.81E+3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 4.52E+3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 9.90E+3nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: 1.06E+4nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
TargetGlutamate receptor ionotropic, NMDA 1(Homo sapiens (Human))
Center For Neurologic Study
US Patent
Center For Neurologic Study
US Patent
Affinity DataKi: >2.30E+4nMAssay Description:In vitro binding assays for the phencyclidine site of NMDA-type glutamate receptors, and for sigma-1 receptors, both of which are known to be bound b...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.0270nMAssay Description:Binding affinity against Opioid receptor mu 1 in guinea pig brain homogenate using [3H]- PL-17 as radioligandMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.0350nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.0470nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.0740nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.0770nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.0770nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0910nMAssay Description:Inhibition of [3H]-PL-17 binding to mu opioid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.110nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.114nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.114nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.116nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.210nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 1(Homo sapiens (Human))
Arena Pharmaceuticals
Curated by ChEMBL
Arena Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.230nMAssay Description:Agonist activity at human S1P1 receptor assessed as change in cAMP level by homogeneous time resolved fluorescence cyclase assayMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 1(Homo sapiens (Human))
Arena Pharmaceuticals
Curated by ChEMBL
Arena Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.230nMAssay Description:Agonist activity at human S1P1 receptor assessed as change in cAMP level by homogeneous time resolved fluorescence cyclase assayMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.231nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.231nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.285nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 0.362nMAssay Description:Binding affinity against Opioid receptor mu 1 in guinea pig brain homogenate using [3H]- PL-17 as radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 0.380nMAssay Description:Inhibition of [3H]-PL-17 binding to mu opioid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.391nMAssay Description:Binding affinity against Opioid receptor kappa 1 in guinea pig brain homogenate using [3H]- U-69593 as radioligandMore data for this Ligand-Target Pair
Affinity DataIC50: 0.400nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.420nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
Affinity DataIC50: 0.475nMAssay Description:Inhibition of [3H]-DPDPE binding to delta opioid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:The compounds of the present invention obtained in the Production Examples were examined for the inhibitory effect on human monoamineoxydase enzymes ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.522nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Cavia porcellus (domestic guinea pig))
University Of Arizona
Curated by ChEMBL
University Of Arizona
Curated by ChEMBL
Affinity DataIC50: 0.593nMAssay Description:Inhibition of [3H]-U-69,593 binding to kappa opoid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
Affinity DataIC50: 0.600nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair
Affinity DataIC50: 0.674nMAssay Description:Inhibition of [3H]-PL-17 binding to mu opioid receptor of guinea pig brain homogenateMore data for this Ligand-Target Pair
Affinity DataIC50: 0.700nMAssay Description:The compounds of the present invention obtained in Production Examples were examined for the inhibitory effect on human and rat VAP-1 enzyme (SSAO) b...More data for this Ligand-Target Pair